Key result
Proteinuria was independently associated with an increased risk of heart failure events in patients with atrial fibrillation (adjusted HR 1.40; 95% CI 1.13-1.74).
Why the study?
Proteinuria is associated with AF and cardiovascular events such as stroke, but its association with heart failure events in patients with AF remains unclear.
Does proteinuria increase the risk of heart failure events in patients with atrial fibrillation?
Cohort (n=2,164)
Does proteinuria increase the risk of heart failure events in patients with atrial fibrillation?
Hazard Ratio: 1.4 (95% CI 1.13–1.74)
Absolute Event Rate: 4.1% vs 2.1%
p-value: p=<0.01
Proteinuria is an independent risk factor for heart failure events (cardiac death or HF hospitalization) in Japanese patients with atrial fibrillation.
May aid HF risk stratification in AF; hypothesis-generating pending prospective trials.
AIMS: Previous studies have shown that proteinuria is independently associated with the incidence of atrial fibrillation (AF), and is also associated with the incidence of cardiovascular events such as stroke and thromboembolism in patients with AF. However, the association of proteinuria with heart failure (HF) events in patients with AF remains unclear. METHODS AND RESULTS: The Fushimi AF Registry is a community-based prospective study of patients with AF. Of the entire cohort of 4489 patients, 2164 patients had available data of proteinuria. We compared the clinical background and outcomes between patients with proteinuria (n = 606, 28.0%) and those without (n = 1558, 72.0%). Patients with proteinuria were older and had a higher prevalence of major co-morbidities. During the median follow-up of 5.0 years, the incidence rates of HF events (composite of cardiac death or HF hospitalization) were higher in patients with proteinuria than those without (4.1% vs. 2.1% person-year, P < 0.01). Multivariate analyses revealed that proteinuria was an independent risk factor of the incidence of HF events [adjusted hazard ratio (HR): 1.40, 95% confidence interval (CI): 1.13-1.74]. This association was consistent among the various subgroups, except for the age subgroup in which there was a significant interaction (P < 0.01) between younger (<75 years) (unadjusted HR: 3.03, 95% CI: 2.12-4.34) and older (≥75 years) patients (unadjusted HR: 1.59, 95% CI: 1.23-2.05). CONCLUSION: Our community-based large prospective cohort suggests that proteinuria is independently associated with the incidence of HF events in Japanese patients with AF.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2023) conducted a cohort in Atrial fibrillation (n=2,164). Proteinuria vs. No proteinuria was evaluated on Heart failure events (composite of cardiac death or HF hospitalization) (HR 1.40, 95% CI 1.13-1.74, p=<0.01). Proteinuria was independently associated with an increased risk of heart failure events in patients with atrial fibrillation (adjusted HR 1.40; 95% CI 1.13-1.74).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: